Clarfeld Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Clarfeld Financial Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$9K	Buy	+171	New	+$8.65K	0.01%	240

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Clarfeld Financial Advisors's EW Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in Edwards Lifesciences (EW) in Q4 2018: 171 shares worth $9K. The stake represents 0.01% of the portfolio and ranks #240 among its holdings.

875 funds tracked by Wall St. Rank hold EW as of Q4 2018.

Clarfeld Financial Advisors held 171 shares of Edwards Lifesciences worth $9K as of Q4 2018.
Edwards Lifesciences was a new Clarfeld Financial Advisors position in Q4 2018.
Edwards Lifesciences made up 0.01% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #240 holding.
875 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.